TOT BIOPHARM INTERNATIONAL COMPANY LIMITED

Andere talen TOT BIOPHARM International Company Limited

Aandelen

1875

HK0000545266

Beurs gesloten - Hong Kong S.E. Andere beurzen 10:08:20 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,68 ^HKD	+6,33%		+8,39%	-14,72%

15/03	TOT BIOPHARM International Company Limited rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	Verlies TOT Biopharm kleiner in H1	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
TOT Biopharm's Loss Narrows in January-September Period	10/11
TOT Biopharm's Loss Narrows in H1	14-08-23
TOT BIOPHARM International Company Limited Announces Directorate and Committee Changes	11-08-23
TOT BIOPHARM International Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	11-08-23
TOT BIOPHARM's Q1 Loss Widens Despite Higher Revenue	12-05-23
TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23
TOT Biopharm Terminates Phase 3 Trial of Breast Cancer Drug; Shares Fall 5%	20-03-23
TOT BIOPHARM International Company Limited Announces Termination of Phase III Clinical Trial Study and Development of Taa013	17-03-23
TOT BIOPHARM’s Production Base for Antibody Drug Receives Good Manufacturing Report from Europe	26-10-22
TOT BIOPHARM International Company Limited Announces Change of Address of Registered Office	15-08-22
TOT Biopharm International Logs Reduction in H1 Net Loss; Shares Climb 3%	15-08-22
TOT BIOPHARM International Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	12-08-22
Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOP BIOPHARM Shares	01-06-22
TOT BIOPHARM International Company Limited announced that it expects to receive HKD 110 million in funding from Center Laboratories, Inc.	31-05-22
TOT Biopharm Narrows Loss on Lower Selling, R&D Expenses in 2021	25-03-22
TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	24-03-22
TOT BIOPHARM International Company Limited Announces Change of Directors and Change of Composition of Board Committees	13-03-22
China Approves New Indications for TOT Biopharm's Cancer Drug	10-03-22
TOT BIOPHARM International Company Limited Announces Change of Joint Company Secretary and Finance Personnel	31-01-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen TOT BIOPHARM International Company Limited

Aandelen

1875

HK0000545266

Andere talen

Filters